D614G and SARS-CoV-2 replication fitness
Signal Transduct Target Ther
.
2021 Mar 1;6(1):99.
doi: 10.1038/s41392-021-00498-3.
Authors
Kathleen D Engelman
1
,
Alan N Engelman
2
3
Affiliations
1
MassBiologics, University of Massachusetts Medical School, Boston, MA, USA.
2
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
[email protected]
.
3
Department of Medicine, Harvard Medical School, Boston, MA, USA.
[email protected]
.
PMID:
33649290
PMCID:
PMC7919242
DOI:
10.1038/s41392-021-00498-3
No abstract available
Publication types
Research Support, N.I.H., Extramural
Comment
MeSH terms
COVID-19*
Humans
Mutation
SARS-CoV-2*
Spike Glycoprotein, Coronavirus / genetics
Substances
Spike Glycoprotein, Coronavirus
Grants and funding
R37 AI039394/AI/NIAID NIH HHS/United States
R01 AI052014/AI/NIAID NIH HHS/United States
P40 OD028116/OD/NIH HHS/United States
R24 OD028257/OD/NIH HHS/United States
U24 AI126683/AI/NIAID NIH HHS/United States